Inclusion

Exclusion

• Males and females aged over 18 years

• Females using a prescribed form of birth control (e.g., oral contraceptive)

• Experiencing three or more of the following symptoms of gastrointestinal discomfort including bloating, flatulence, diarrhoea, constipation, reflux, heart burn, abdominal pain/discomfort experienced at least 3 days in the last month

• Normal dietary habits (no FODMAP diet, elimination diet, vegan diet, etc) with a minimum 2-month period of self-reported dietary stability.

• Agree to not change current diet or exercise regime during entire study period

• Agree to not use any other dietary supplements or digestive enzymes during the study period

• Able to provide informed consent

• Unstable or serious illness (e.g., kidney, liver, GIT, heart conditions, diabetes, thyroid gland function Malignancy)

• People with a past or current history of inflammatory bowel disease or gastrointestinal tract surgery

• Pregnant or breastfeeding mothers

• Malignancy or treatment for malignancy within the previous 2 years

• Receiving/ prescribed coumadin (Warfarin), heparin, dalteparin, enoxaparin or other anticoagulation therapy including low dose aspirin

• Active smokers, nicotine, alcohol, drug abuse

• Chronic past and/or current alcohol use (>14 alcoholic drinks week)

• Allergic to any of the ingredients in active or placebo formula

• Any history of kiwi fruit allergy

• Those suffering from insomnia or have night-shift employment and unable to have a normal night’s sleep

• People suffering any neurological disorders such as MS

• Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion (including hypercholesterolemia)

• Participants who have participated in any other clinical trial during the past 3 months

• Clinically significant acute or chronic inflammation, or connective tissue disease or arthritis

• History of infection in the month prior to the study or taking antibiotic therapy

• Hydration therapy during study period